methotrexate has been researched along with Aortic Arteritis, Giant Cell in 109 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.92) | 18.7374 |
1990's | 13 (11.93) | 18.2507 |
2000's | 32 (29.36) | 29.6817 |
2010's | 33 (30.28) | 24.3611 |
2020's | 30 (27.52) | 2.80 |
Authors | Studies |
---|---|
Ercole, L; González-Gay, MA; Ortego-Centeno, N | 1 |
Becker, J; Bley, TA; Hellmich, B; Kraemer, M; Minnerup, J; Steinbrecher, A | 1 |
Camellino, D; Caporali, R; Carrara, G; Cimmino, MA; Crotti, C; De Vita, S; El Aoufy, K; Emmi, G; Monti, S; Morbelli, S; Muratore, F; Padoan, R; Quartuccio, L; Rozza, D; Salvarani, C; Sciascia, S; Tonolo, S; Ughi, N; Zanetti, A | 1 |
Bolhuis, TE; den Broeder, AA; den Broeder, N; Marsman, DE; van der Maas, A | 1 |
Aussedat, M; Cucherat, M; Durieu, I; Grenet, G; Gueyffier, F; Lega, JC; Lobbes, H; Mainbourg, S; Samson, M; Tabary, A | 1 |
Darrow, HJ; Raleigh, MF; Stoddard, J | 1 |
Horák, P; Hraboš, D; Skácelová, M; Skoumalová, A; Videman, J | 1 |
Brugarolas, E; Estrada, P; LLop, D; Maymó-Paituvi, P; Narváez, J; Nolla, JM; Palacios-Olid, J; Vidal-Montal, P | 1 |
Akahoshi, M; Boyadzhieva, Z; Buttgereit, F; Hermann, S; Muche, B; Palmowski, A; Terao, C; Wiebe, E | 1 |
Man-Ger Sun, M; Pope, JE | 1 |
Aouba, A; Boutemy, J; de Boysson, H; Deshayes, S; Dumont, A; Gallou, S; Lavergne, A; Maigné, G; Nguyen, A; Philip, R; Silva, NM | 1 |
Bonnotte, B; Greigert, H; Samson, M | 1 |
Hernández, C; Karsulovic, C; Mac-Namara, M; Sabugo, F; Wurmann, P; Zamorano, P | 1 |
Villiger, PM | 1 |
Águeda, AF; Buttgereit, F; Cid, M; Dejaco, C; Hellmich, B; Luqmani, RA; Mahr, A; Monti, S; Ponte, C; Salvarani, C; Schmidt, W | 1 |
Allali, D; Blondon, M; Roux-Lombard, P; Spoerl, D | 1 |
Black, R; Hill, C; Nguyen, L; Proudman, S; Ruediger, C | 1 |
Hellmich, B; Horvath, L | 1 |
Holle, JU; Moosig, F | 1 |
Schmidt, WA | 1 |
Mahmood, SB; Nasr, R; Nelson, E; Padniewski, J | 1 |
Buttgereit, F; Dejaco, C; Matteson, EL | 1 |
Águeda, AF; Hellmich, B; Luqmani, R; Monti, S | 1 |
Buttgereit, F; Palmowski, A | 1 |
Lee, YH; Song, GG | 1 |
Hellmich, B | 2 |
Boiardi, L; Casali, M; Cavallaro, A; Corte, G; Crescentini, F; Galli, E; Kuwert, T; Manger, B; Muratore, F; Rech, J; Roth, J; Salvarani, C; Schett, G; Schmidt, D; Schönau, V; Spaggiari, L; Tascilar, K; Uder, M; Versari, A | 1 |
Matsushita, S; Taito, S; Yamamoto, N | 1 |
Cacoub, P; Dechartres, A; Gérard, AL; Saadoun, D; Simon-Tillaux, N; Tubach, F; Yordanov, Y | 1 |
Garvey, TD; Koster, MJ; Warrington, KJ | 1 |
Deuter, C; Kötter, I; Stübiger, N | 1 |
Aggarwal, I; Berry, GJ; Liao, YJ; Sab, UK; Uribe, JA; Weyand, CM; Witthayaweerasak, J | 1 |
Boers, N; den Broeder, AA; Marsman, DE; van der Maas, A | 1 |
Berti, A; Cornec, D; Matteson, EL; Medina Inojosa, JR; Murad, MH | 1 |
Blanco, R; Calderon-Goercke, M; Castañeda, S; González-Gay, MA; Pina, T; Prieto-Peña, D | 1 |
Crowson, CS; Koster, MJ; Labarca, C; Muratore, F; Warrington, KJ; Yeruva, K | 1 |
Diamantopoulos, AP; Myklebust, G; Tengesdal, S | 1 |
Calderon-Goercke, M; Castañeda, S; González-Gay, MÁ; Gualillo, O; Pina, T; Prieto-Peña, D | 1 |
Brouwer, E; Sandovici, M; VAN DER Geest, KSM | 1 |
Agueda, A; Brouwer, E; Buttgereit, F; Cassie, R; Cid, MC; Dasgupta, B; de Boysson, H; Dejaco, C; Hatemi, G; Hellmich, B; Hollinger, N; Luqmani, RA; Mahr, A; Mollan, SP; Monti, S; Mukhtyar, C; Ponte, C; Salvarani, C; Schmidt, W; Sivakumar, R; Tian, X; Tomasson, G; Turesson, C; Villiger, PM; Watts, R; Young, C | 1 |
Bonnotte, B; Ghesquière, T; Greigert, H; Samson, M | 1 |
Belhassen, M; Devauchelle-Pensec, V; Gandon, S; Hachulla, E; Idier, I; Mahr, A; Nolin, M; Paccalin, M | 1 |
Abrantes, F; Bacchiega, AB; Okamoto, KY; Schau, B; Shinjo, SK; Souza, AW | 1 |
Loke, YK; MacGregor, AJ; Watts, RA; Yates, M | 1 |
Berti, A; Campochiaro, C; Cavalli, G; Dagna, L; Doglioni, C; Gerevini, S; Guglielmi, B; Sabbadini, MG | 1 |
Hisada, R; Jodo, S | 1 |
Magliano, M; Mankia, KS; Tucker, LJ | 1 |
Cei, M; Dentali, F; Mumoli, N; Vitale, J | 1 |
Barreto, P; Fior, A | 1 |
Eiber, M; Einspieler, I; Thürmel, K | 1 |
Buttgereit, F; Dasgupta, B; Dejaco, C; Matteson, EL | 2 |
Alivernini, S; Berardi, G; Biscetti, F; Bosello, SL; Carbonella, A; Fedele, AL; Ferraccioli, G; Gremese, E; Petricca, L | 1 |
Pastor-Asurza, C; Pimentel-Quiroz, VR; Sumire-Umeres, J; Ugarte-Gil, M | 1 |
Bienvenu, B; de Boysson, H; Samson, M; Watelet, B | 1 |
Muratore, F; Pipitone, N; Salvarani, C | 1 |
Liozon, E; Ly, K | 1 |
Corchero, C; Diaz-Lopez, C; Diaz-Torne, C; Narvaez, J; Nolla, JM; Pou, MA; Vidal, S | 1 |
Biousse, V; Fraser, JA; Newman, NJ; Weyand, CM | 1 |
Hall, JK | 1 |
Märker-Hermann, E; Schmidt, WA | 1 |
Agudo, M; Blanco, R; Gonzalez-Gay, MA; Llorca, J; Martinez-Dubois, C; Pompei, O | 1 |
Balsalobre Aznar, J; Porta-Etessam, J | 1 |
Alba, MA; Flores-Suárez, LF; Mena-Madrazo, JA; Reyes, E | 1 |
Borchers, AT; Gershwin, ME | 1 |
Besada, E; Nossent, JC | 1 |
Ameloot, K; De Wever, W; Goffin, K; Palmers, PJ; Voigt, JU | 1 |
Baca, S; Bork, D; Calabrese, LH; Choi, HK; Cid, MC; Cohen, P; Dickler, H; Easley, KA; Ferland, D; Fessler, BJ; Flynn, JA; Fortin, P; Gross, W; Guillevin, L; Hellmann, DB; Hernández-Rodríguez, J; Hoffman, DB; Hoffman, GS; Hunder, GG; Kalunian, K; Klashman, D; Kosmorsky, G; Locker, GA; Lopez-Soto, A; Ludivico, C; Luqmani, RA; Mandell, BF; McRorie, E; Merkel, PA; Nuki, G; Prayson, R; Puechal, X; Scheetz, RJ; Schned, E; Schousboe, J; Segal, AM; Sherrer, Y; Sneller, MC; Soubrier, M; Stone, JH; Swanson, H; Tuggle, C; Walsh, B; Wilke, WS | 1 |
Ben-Ami, H; Fruchter, O; Gaitini, D; Gallimidi, Z; Goldsher, D; Schapira, D | 1 |
Schnabel, A | 1 |
Bañares, A; Fernandez-Gutierrez, B; Hernández-Garcia, C; Jover, JA; Morado, IC; Vargas, E | 2 |
Kupersmith, M; Paget, S; Spiera, H; Spiera, RF | 1 |
Caceres, LR; Lichtstein, DM | 1 |
Seton, M | 1 |
Sailler, L | 1 |
Bañuls, SR; Ripoll, JM; Sanchis, AM; Zaragoza, JM | 1 |
Heathcote, JG; Proulx, A; Rizkalla, K; Rodrigues, S; Tingey, DP | 1 |
Boulman, N; Eder, L; Feld, J; Rimar, D; Rosner, I; Rozenbaum, M; Slobodin, G; Zisman, D | 1 |
Machera, H; Skoura, C; Spanou, A; Zachariades, N | 1 |
Randhawa, S; Van Stavern, GP | 1 |
Fernández-Gutiérrez, B; Hernández-García, C; Jover, JA; Lavalley, MP; Mahr, AD; Merkel, PA; Spiera, RF | 1 |
Yazici, Y | 1 |
Cid, MC; Espígol-Frigolé, G; García-Martínez, A; Hernández-Rodríguez, J; Lozano, E | 1 |
Käser, L; Kolyvanos Naumann, U; Nigg, C; Vetter, W | 1 |
Danesh-Meyer, HV; Savino, PJ | 1 |
Pipitone, N; Salvarani, C | 1 |
Hoffman, GS; Wilke, WS | 1 |
Bañares, A; Fernández-Gutiérrez, B; Hernández-García, C; Herrero, M; Jover, JA; Morado, C; Ramos, P; Soriano, C | 1 |
Nesher, G; Sonnenblick, M | 1 |
Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ | 1 |
Hoffman, GS; Langford, CA; Sneller, MC | 1 |
Bahlas, S; Davis, P; Ramos-Remus, C | 1 |
Mantaka, P; Nüsslein, H; Schwarz-Eywill, M; Unger, L; Wittek, A | 1 |
Giuliani, MJ; Lacomis, D; Oddis, CV; Wasko, MC | 1 |
Roblot, P | 1 |
Kupersmith, MJ; Langer, R; Mitnick, H; Paget, S; Richmond, M; Spiera, H; Spiera, R | 1 |
Généreau, T | 1 |
Gibbons, RB; Krebs, S | 1 |
Bie, RB; Haugeberg, G; Paulsen, PQ | 1 |
Alarcón, GS; Morgan, SL | 1 |
Paget, S; Spiera, H; Spiera, RF | 1 |
Hellmann, DB; Levine, SM | 1 |
Barilla-LaBarca, ML; Brasington, RD; Lenschow, DJ | 1 |
Airò, P; Antonioli, CM; Toniati, P; Vianelli, M | 1 |
Hoffman, GS | 1 |
Krall, PL; Mazanec, DJ; Wilke, WS | 1 |
52 review(s) available for methotrexate and Aortic Arteritis, Giant Cell
Article | Year |
---|---|
[Diagnostics and treatment of giant cell arteritis].
Topics: Drug Therapy, Combination; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Recurrence | 2022 |
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis.
Topics: Giant Cell Arteritis; Humans; Italy; Methotrexate; Rheumatology; Takayasu Arteritis | 2022 |
Indirect Comparison of Glucocorticoid-Sparing Agents for Remission Maintenance in Giant Cell Arteritis: A Network Meta-analysis.
Topics: Adalimumab; Etanercept; Giant Cell Arteritis; Glucocorticoids; Humans; Infliximab; Methotrexate; Network Meta-Analysis; Randomized Controlled Trials as Topic | 2022 |
Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies.
Topics: Antirheumatic Agents; Cohort Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Leflunomide; Methotrexate; Recurrence; Takayasu Arteritis | 2023 |
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica | 2022 |
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Biomarkers; Blindness; Drug Therapy, Combination; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Methotrexate; Observational Studies as Topic; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Recurrence; Risk Management; Systemic Vasculitis; Takayasu Arteritis | 2019 |
[Treatment of giant cell arteritis: what is in the pipeline?]
Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction; Treatment Outcome | 2020 |
[Inflammatory Muscle Pain: Polymyalgia Rheumatica with or without Large Vessel Vasculitis].
Topics: Aged; Antibodies, Monoclonal, Humanized; Blindness; Diagnosis, Differential; Fatigue; Female; Giant Cell Arteritis; Humans; Methotrexate; Polymyalgia Rheumatica; Prednisolone; Stroke; Ultrasonography; Vasculitis | 2020 |
Polymyalgia rheumatica: An updated review.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Ultrasonography | 2020 |
Polymyalgia Rheumatica and Giant Cell Arteritis.
Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography | 2020 |
Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Recurrence; Takayasu Arteritis | 2020 |
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.
Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Takayasu Arteritis | 2020 |
Methotrexate for treating polymyalgia rheumatica: A meta-analysis of randomized controlled trials.
Topics: Antirheumatic Agents; Giant Cell Arteritis; Humans; Methotrexate; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
[Glucocorticoids in the treatment of giant cell arteritis : How much, how long and how to spare?]
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Osteoporosis; Recurrence | 2021 |
Efficacy and safety of steroid-sparing treatments in giant cell arteritis according to the glucocorticoids tapering regimen: A systematic review and meta-analysis.
Topics: Drug Therapy, Combination; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Steroids | 2021 |
My Treatment Approach to Giant Cell Arteritis.
Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Remission Induction | 2021 |
[Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Arthritis, Rheumatoid; Aspirin; Collagen Diseases; Cross-Sectional Studies; Eye Diseases; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Lupus Erythematosus, Systemic; Methotrexate; Retinal Diseases; Scleritis; Uveitis, Anterior; Vascular Diseases | 2017 |
Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis.
Topics: Aged; Autoantibodies; Autoantigens; Blindness; Computed Tomography Angiography; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Meningitis; Methotrexate; Optic Atrophy; Prednisone; Retina; Retinal Diseases | 2018 |
[Polymyalgia rheumatica: new developments and challenges].
Topics: Diagnosis, Differential; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography | 2017 |
Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome | 2018 |
Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
Topics: Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal, Humanized; Biological Therapy; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Receptors, Interleukin-6 | 2018 |
Treatment of giant cell arteritis.
Topics: Animals; Antibodies, Monoclonal, Humanized; Biological Factors; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome | 2019 |
[Treatment of giant cell arteritis].
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Aspirin; Azathioprine; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Leflunomide; Methotrexate; Prednisone; Ustekinumab | 2019 |
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dapsone; Female; Giant Cell Arteritis; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Treatment Outcome; Vasculitis | 2014 |
Giant cell arteritis.
Topics: Aged; Cyclophosphamide; Diagnostic Imaging; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Prognosis; Pulse Therapy, Drug; Temporal Arteries | 2013 |
Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
Topics: Disease Management; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Polymyalgia Rheumatica; Shoulder Joint; Temporal Arteries; Ultrasonography | 2016 |
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Topics: Antibodies, Monoclonal, Humanized; Diagnostic Imaging; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Randomized Controlled Trials as Topic | 2016 |
[Management of polymyalgia rheumatica and large vessel vasculitis].
Topics: Antirheumatic Agents; Biological Products; Combined Modality Therapy; Evidence-Based Medicine; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Patient Care Management; Polymyalgia Rheumatica; Treatment Outcome | 2016 |
Treatment of giant-cell arteritis, a literature review.
Topics: Antirheumatic Agents; Azathioprine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Giant Cell Arteritis; Glucocorticoids; Humans; Medication Therapy Management; Methotrexate; Tumor Necrosis Factor-alpha | 2017 |
Standard and biological treatment in large vessel vasculitis: guidelines and current approaches.
Topics: Animals; Antibodies, Monoclonal; Azathioprine; Biological Therapy; Clinical Trials as Topic; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphotoxin-alpha; Methotrexate; Practice Guidelines as Topic; Recurrence; Remission Induction; Takayasu Arteritis | 2017 |
[Giant cell arteritis].
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Infective Agents; Biopsy; Blood Sedimentation; C-Reactive Protein; Dapsone; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Recurrence; Temporal Arteries; Time Factors; Ultrasonography, Doppler, Duplex | 2008 |
The treatment of giant cell arteritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Brain Ischemia; Drug Administration Schedule; Fibrinolytic Agents; Giant Cell Arteritis; Hospitalization; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Optic Neuropathy, Ischemic | 2008 |
Giant-cell arteritis.
Topics: Aspirin; Blood Sedimentation; C-Reactive Protein; Fibrinogen; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Interleukin-6; Magnetic Resonance Angiography; Methotrexate; Platelet Count; Radiopharmaceuticals; Ultrasonography, Doppler, Color | 2008 |
[Polymyalgia rheumatica].
Topics: Adrenal Cortex Hormones; Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Polymyalgia Rheumatica; Tumor Necrosis Factor-alpha | 2009 |
Giant cell arteritis: epidemiology, diagnosis, and management.
Topics: Biopsy; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Temporal Arteries; Ultrasonography | 2010 |
[Temporal arteritis: treatment controversies].
Topics: Aspirin; Benzamides; Giant Cell Arteritis; Glucocorticoids; Humans; Imatinib Mesylate; Immunosuppressive Agents; Methotrexate; Middle Aged; Optic Neuropathy, Ischemic; Piperazines; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Pyrimidines | 2010 |
Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment.
Topics: Aorta; Aortic Aneurysm; Aspirin; Azathioprine; Dendritic Cells; Female; Giant Cell Arteritis; Humans; Macrophages; Magnetic Resonance Angiography; Male; Methotrexate; Positron-Emission Tomography; Sex Factors; T-Lymphocytes; Temporal Arteries; Ultrasonography | 2012 |
Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Aspirin; Biopsy; Drug Resistance; Drug Therapy, Combination; Edema; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisolone; Temporal Arteries; Ultrasonography, Doppler, Duplex | 2012 |
[What have we learned about giant cell arteritis during the last decade?].
Topics: Adrenal Cortex Hormones; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Prognosis; Risk Factors | 2004 |
Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
Topics: Administration, Oral; Aged; Chemotherapy, Adjuvant; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Male; MEDLINE; Methotrexate; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2007 |
Vasculitis update, 2007.
Topics: Adrenal Cortex Hormones; Anticoagulants; Antirheumatic Agents; Aspirin; Cyclophosphamide; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Humans; Methotrexate | 2007 |
Five clinical conundrums in the management of giant cell arteritis.
Topics: Abortifacient Agents, Nonsteroidal; Aorta; Aortography; Azathioprine; Dilatation, Pathologic; Giant Cell Arteritis; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methotrexate; Prednisone; Pulse Therapy, Drug; Tomography, Spiral Computed; Vision Disorders | 2007 |
Giant cell arteritis.
Topics: Adrenal Cortex Hormones; Biopsy; Drug Administration Schedule; Giant Cell Arteritis; Humans; Methotrexate; Methylprednisolone; Platelet Aggregation Inhibitors; Prognosis; Vision Disorders | 2007 |
Improving therapeutic options for patients with giant cell arteritis.
Topics: Antibodies, Monoclonal; Azathioprine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Randomized Controlled Trials as Topic; Tumor Necrosis Factor-alpha | 2008 |
Treatment of corticosteroid-resistant giant cell arteritis.
Topics: Adrenal Cortex Hormones; Drug Resistance; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Prospective Studies; Time Factors; Treatment Outcome | 1995 |
Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.
Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Methotrexate; Prednisone | 1994 |
Methotrexate use in systemic vasculitis.
Topics: Antirheumatic Agents; Clinical Trials as Topic; Female; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Prospective Studies; Takayasu Arteritis; Treatment Outcome | 1997 |
[Immunosuppressive agents in Horton's disease. Which drug for which indication?].
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Resistance; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Patient Selection; Steroids | 1998 |
Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Drug Therapy, Combination; Fatal Outcome; Female; Giant Cell Arteritis; Humans; Immunocompromised Host; Methotrexate; Pneumonia, Pneumocystis; Prednisone; Risk Factors | 1996 |
Giant cell arteritis.
Topics: Antirheumatic Agents; Giant Cell Arteritis; Humans; Methotrexate; Risk Factors | 2002 |
Polymyalgia rheumatica/temporal arteritis: recent advances.
Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Treatment of giant-cell arteritis: where we have been and why we must move on.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Aortic Aneurysm; Azathioprine; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Prednisolone | 2002 |
7 trial(s) available for methotrexate and Aortic Arteritis, Giant Cell
Article | Year |
---|---|
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Multicenter Studies as Topic; Polymyalgia Rheumatica; Prednisolone; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Blood Sedimentation; Double-Blind Method; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Recurrence; Treatment Failure | 2002 |
Methotrexate treatment in the management of giant cell arteritis.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Treatment Outcome | 1994 |
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Recurrence | 1996 |
Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.
Topics: Adrenal Cortex Hormones; Aged; Color Vision Defects; Contrast Sensitivity; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Methylprednisolone; Prednisolone; Prospective Studies; Sensory Thresholds; Vision Disorders; Visual Acuity | 1999 |
Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
Topics: Adrenal Cortex Hormones; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Male; Methotrexate; Placebos; Prednisone; Recurrence; Sensitivity and Specificity; Statistics, Nonparametric | 2001 |
Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Drug Resistance; Drug Therapy, Combination; Female; Giant Cell Arteritis; Health Status; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Pain; Pain Measurement; Prednisone; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2002 |
50 other study(ies) available for methotrexate and Aortic Arteritis, Giant Cell
Article | Year |
---|---|
Clinical practice in giant cell arteritis based on a survey of specialists.
Topics: Cross-Sectional Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Surveys and Questionnaires | 2022 |
Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review.
Topics: C-Reactive Protein; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Myalgia; Polymyalgia Rheumatica; Recurrence | 2022 |
Treatment of giant cell arteritis - current approach and new possibilities.
Topics: Biological Factors; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Positron Emission Tomography Computed Tomography | 2022 |
No association between methotrexate and impaired bone mineral density in a cohort of patients with polymyalgia rheumatica, giant cell arteritis, granulomatosis with polyangiitis and other vasculitides-a cross-sectional analysis with dose-response analyses
Topics: Aged; Bone Density; Cohort Studies; Cross-Sectional Studies; Giant Cell Arteritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Methotrexate; Middle Aged; Polymyalgia Rheumatica | 2023 |
Efficacy and tolerance of methotrexate in a real-life monocentric cohort of patients with giant cell arteritis.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Recurrence; Retrospective Studies | 2023 |
[Treatment of giant cell arteritis].
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate | 2023 |
[Giant cell arteritis. Experience in 32 patients].
Topics: Aged; Aged, 80 and over; Biopsy; C-Reactive Protein; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Steroids; Temporal Arteries | 2022 |
[Large-vessel vasculitis-giant cell and Takayasu arteritis].
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Female; Giant Cell Arteritis; Giant Cells; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisone; Takayasu Arteritis; Treatment Outcome | 2019 |
[How to manage giant cell arteritis].
Topics: Abatacept; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Ultrasonography | 2020 |
Efficacy of methotrexate in polymyalgia rheumatica in routine rheumatology clinical care.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Polymyalgia Rheumatica; Rheumatology | 2020 |
[Treatment of giant cell arteritis and polymyalgia rheumatica].
Topics: Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica | 2020 |
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Inflammation; Male; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisolone; Treatment Outcome | 2021 |
Does methotrexate have no beneficial effect in reducing flares in the treatment of polymyalgia rheumatica patients?
Topics: Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica | 2021 |
Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
Topics: Academic Medical Centers; Aged; Biopsy, Needle; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; North America; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Leflunomide versus methotrexate in treatment of giant cell arteritis: comparison of efficacy, safety, and drug survival.
Topics: Aged; Antirheumatic Agents; Dose-Response Relationship, Drug; Drug Monitoring; Female; Giant Cell Arteritis; Humans; Leflunomide; Male; Methotrexate; Norway; Patient Acuity; Prednisolone; Remission Induction; Retrospective Studies; Treatment Outcome | 2019 |
Methotrexate in Giant Cell Arteritis Deserves a Second Chance - A High-dose Methotrexate Trial Is Needed.
Topics: Case-Control Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Prednisone | 2019 |
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Aortitis; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Takayasu Arteritis | 2020 |
Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data.
Topics: Aged; Antirheumatic Agents; Biopsy; Databases, Factual; Female; France; Giant Cell Arteritis; Humans; Incidence; Male; Methotrexate; National Health Programs; Retrospective Studies; Temporal Arteries; Ultrasonography, Doppler | 2020 |
Giant cell arteritis: a multicenter observational study in Brazil.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Biopsy; Brazil; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Sex Factors; Statistics, Nonparametric; Temporal Arteries | 2013 |
Methotrexate in refractory bilateral juvenile temporal arteritis: Report of a case.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Giant Cell Arteritis; Humans; Male; Methotrexate; Retreatment; Temporal Arteries; Treatment Outcome | 2016 |
Extra-cranial giant cell arteritis: a diagnostic challenge.
Topics: Aged; C-Reactive Protein; Female; Giant Cell Arteritis; Humans; Methotrexate; Middle Aged; Platelet Transfusion; Positron-Emission Tomography; Prednisolone; Thrombocytopenia | 2015 |
Tongue necrosis in giant-cell arteritis.
Topics: Aged; Biopsy; Diphosphonates; Female; Giant Cell Arteritis; Humans; Methotrexate; Necrosis; Prednisone; Tongue; Vitamin D | 2015 |
Isolated aortitis: a rare cause of febrile illness.
Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Aortitis; Diagnosis, Differential; Female; Fever; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisolone; Rare Diseases; Takayasu Arteritis; Treatment Outcome | 2015 |
Fully integrated whole-body [18F]-fludeoxyglucose positron emission tomography/magnetic resonance imaging in therapy monitoring of giant cell arteritis.
Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Magnetic Resonance Angiography; Male; Methotrexate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone.
Topics: Adrenal Cortex Hormones; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Male; Methotrexate; Retrospective Studies | 2016 |
Coronary and Aortic Involvement as Initial Manifestations of Possible Giant Cell Arteritis in a Patient Without Cardiovascular Comorbidities.
Topics: Aged; Antirheumatic Agents; Biopsy; Coronary Artery Bypass; Coronary Disease; Diagnosis, Differential; Exercise Test; Female; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Methotrexate | 2016 |
Development of autoimmune diseases after vaccination.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Influenza Vaccines; Male; Methotrexate; Prednisone; Tetanus Toxoid | 2008 |
Giant cell arteritis in Mexican patients.
Topics: Aged; Aged, 80 and over; Amaurosis Fugax; Antirheumatic Agents; Blindness; Ethnicity; Female; Follow-Up Studies; Giant Cell Arteritis; Headache; Humans; Male; Methotrexate; Mexico; Middle Aged; Polymyalgia Rheumatica; Prednisone; Retrospective Studies | 2012 |
An echocardiographic finding leading to the diagnosis of giant cell arteritis.
Topics: Aged; Echocardiography, Transesophageal; Fatigue; Follow-Up Studies; Giant Cell Arteritis; Humans; Methotrexate; Methylprednisolone; Positron-Emission Tomography; Risk Assessment; Syncope; Treatment Outcome; Weight Loss | 2013 |
Giant cell arteritis complicated by spinal cord infarction: a therapeutic dilemma.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Giant Cell Arteritis; Humans; Infarction; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Prednisone; Risk Assessment; Spinal Cord; Spinal Cord Ischemia; Treatment Outcome | 2002 |
[Corticosteroid saving-up in giant cell arteritis?].
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Double-Blind Method; Follow-Up Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Time Factors | 2002 |
Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.
Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Multicenter Studies as Topic; Placebos; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Treatment Outcome | 2003 |
Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al.
Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Multicenter Studies as Topic; Placebos; Prednisone; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome; Vision, Low | 2003 |
Heeding clues to giant cell arteritis. Prompt response can prevent vision loss.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blindness; Female; Giant Cell Arteritis; Headache; Humans; Methotrexate; Polymyalgia Rheumatica | 2004 |
Giant cell arteritis in a patient taking etanercept and methotrexate.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Female; Giant Cell Arteritis; Humans; Immunoglobulin G; Methotrexate; Receptors, Tumor Necrosis Factor | 2004 |
First-time manifestation of giant-cell arteritis during methotrexate treatment.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Psoriatic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Methotrexate; Prednisone | 2005 |
Primary intraocular lymphoma arising during methotrexate treatment of temporal arteritis.
Topics: Aged, 80 and over; Biomarkers, Tumor; Biopsy; Eye Enucleation; Female; Giant Cell Arteritis; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphoma, B-Cell; Methotrexate; Retinal Neoplasms | 2005 |
Giant cell arteritis--the methotrexate debate revisited.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Blindness; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisone | 2006 |
Temporal arteritis: report of a case.
Topics: Aged; Angiography; Anti-Inflammatory Agents; Antirheumatic Agents; Biopsy; Blindness; Female; Giant Cell Arteritis; Humans; Methotrexate; Methylprednisolone | 2006 |
Giant cell arteritis presenting with hemianopic visual field loss.
Topics: Aged; Biopsy; Blood Sedimentation; Drug Therapy, Combination; Female; Giant Cell Arteritis; Hemianopsia; Humans; Magnetic Resonance Angiography; Methotrexate; Prednisone; Temporal Arteries; Visual Field Tests; Visual Fields | 2007 |
[Giant cell arteritis].
Topics: Aged; Blood Sedimentation; Diagnosis, Differential; Diagnostic Tests, Routine; Fatigue; Female; Giant Cell Arteritis; Glucocorticoids; Headache; Humans; Methotrexate; Prednisone; Ultrasonography, Doppler, Color; Vision Disorders | 2007 |
Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Polymyalgia Rheumatica; Prednisone | 1998 |
Treating an underdiagnosed cause of headaches.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate | 1998 |
First-time manifestation of generalized Wegener's granulomatosis despite methotrexate.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Middle Aged | 1998 |
Giant cell arteritis presenting with proximal weakness and skeletal muscle vasculitis.
Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Methotrexate; Muscle Weakness; Muscle, Skeletal; Polymyalgia Rheumatica; Prednisone; Vasculitis, Leukocytoclastic, Cutaneous | 1999 |
[Horton's disease and rhizomelic pseudopolyarthritis. First International Congress on Horton's Disease and rhizomelic pseudopolyarthritis, Prato (Italy), 25-26 May 1999].
Topics: Adrenal Cortex Hormones; Aged; Antirheumatic Agents; Diagnosis, Differential; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Italy; Methotrexate; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic | 1999 |
Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chlorambucil; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Norway; Polymyalgia Rheumatica; Prednisolone; Vision Disorders | 2000 |
Methotrexate in giant-cell arteritis.
Topics: Adrenal Cortex Hormones; Aged; Drug Therapy, Combination; Female; Folic Acid; Folic Acid Antagonists; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate | 2001 |
Methotrexate in giant-cell arteritis.
Topics: Adrenal Cortex Hormones; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate | 2001 |
Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone | 1989 |